Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by amorakon Sep 17, 2010 11:18am

629 Views

Post# 17460915

RE: RE: RE: RE: RE: LOL

Get used to it if you're going to be all whimpy like that. What do you want me to say, there, there, everything will be ok!?!?!?!
I'd say that one thing is for sure, RVX has turned the corner in investors' minds. Half a million shares traded in the first two hours on a down day is a pretty good indication of interest.
And JayDee, when a stock runs for a few days like this without a press release that actually defines value then you have to expect 'breather' days like today along the way.

Bullboard Posts

AI companies to invest in